Biome Australia Ltd · ASX:BIO
Biome Australia — Q3 FY22 Earnings Presentation
16 slides from Biome Australia's earnings presentation, Apr 21, 2022
Slide 1: Biome Australia Limited March 2022 Quarterly Update
For personal use only Biome Australia Limited Presentation March 2022 – Quarterly Update Commercial in confidence Blair Norfolk, CEO e: blair@activated.co Douglas Loh, CFO e: douglas@activated.co BIOME AUSTRALIA.COM
Slide 2: Disclaimer
Disclaimer This presentation and the information contained Past performance information included in this The recipient must, and agrees with the For personal use only within it (the “information”) has been prepared presentation is provided for illustrative purposes Company that it will, make its own
Slide 3: Our mission
For personal use only Our mission To prevent disease, improve health outcomes and quality of life, and make our products accessible to all Commercial in confidence PG.3
Slide 4: About Biome Australia
About Biome Australia For personal use only Biome Australia (ASX: BIO) is focused on becoming a global leader in targeted probiotics (live-biotherapeutics), offering clinically-proven condition-specific probiotic products fueled by novel clinical research programs to cement and extend the evidence b
Slide 5: Investment Highlights
Investment Highlights For personal use only Strong financial Widespread Ongoing clinical performance distribution pipeline Record March 22 quarter sales of Over 2,500 distribution points in Successful results from $925k, up 58% vs PCP Australia, an increase of 25% independent asthma & acne since IPO
Slide 6: Investment Highlights
Investment Highlights For personal use only Business model to World class Leading product deliver continued development partners portfolio growth Key partners TWCM, Blooms and Partnered with La Trobe and 23 products across 3 brands: Symbion reported Activated Federation Universities to - Activated P
Slide 7: Activated Probiotics product range
Biome DailyTM Biome IBSTM Activated Probiotics DIGESTIVE Probiotic Probiotic HEALTH To help enhance immune To relieve the symptoms of system function and promote medically diagnosed IBS Practitioners & Pharmacies healthy digestion For personal use only Biome Her Biome Prenatal+TM CONSUMER BENEFITS P
Slide 8: Primary distribution channels
Primary distribution channels Community pharmacy and independent health practitioners For personal use only Australian community pharmacies Complementary medicine practitioners • Over 1,650 pharmacies now carry the Activated • This channel has increased from circa 20% of sales Probiotics range, up 3
Slide 9: Our Australian Distribution Network
Our Australian Distribution Network For personal use only Biome Australia has grown to over 2500 distribution points, including 1650 community pharmacies Our key sales channels are community pharmacy, complementary medicine practitioners and integrative health stores Authorised Distribution Partners
Slide 10: Quarterly Net Sales
Quarterly Net Sales Track record of rapid growth For personal use only FYTD (Mar 22) $2.73m 82.6% growth $1,000,000 vs PCP FYTD (Mar 22) $1.49m $800,000 $600,000 $400,000 $200,000 0 Jun-20 Qtr Sep-20 Qtr Dec-20 Qtr Mar-21 Qtr Jun-21 Qtr Sep-21 Qtr Dec-21 Qtr Mar-22 Qtr Commercial in confidence PG.10
Slide 11: Product ranking by sales
Product ranking by sales March 2022 Quarter For personal use only Rank Product % Share 1 Biome Daily Probiotic 20.0% PRODUCT RANKING 2 Biome Daily Kids Probiotic 15.7% Gut health and immune health are leading 3 Biome Advanced Probiotic (30 caps) 10.3% product by sales volume closely followed 4 Biome
Slide 12: Customer ranking by sales
Customer ranking by sales For personal use only March 22 Qtr FY21 Rank Location Customer % Share % Share 1 Aust Pharmacy Wholesaler A 40.2% 49.1% CUSTOMER RANKING 2 Aust Pharmacy Wholesaler B 27.3% 20.2% Pharmacy customers make up 67.5% of 3 Aust Practitioner Wholesaler A 8.8% 3.2% Biome’s total sal
Slide 13: Corporate Overview
Corporate Overview For personal use only Key Statistics Major Shareholders Existing Shares on issue 199.9m Directors and Management 16.4% Options on issue1 8.1 m Other Staff 3.6% Other Shareholders 80.0% Share Price (20 April 2022) 8.9 cents Net Tangible Asset per share 3.9 cents Total 100.0% Market
Slide 14: Growth strategies
Growth strategies Products supported by clinical evidence For personal use only Immediate term (12 months) • Focus on sales and marketing to improve sell-through to existing customers • Drive growth of Biome Acne and Biome Baby Probiotic launched in H2 2022 – an Acne specific live biotherapeutic and
Slide 15: Strong growth outlook
Strong growth outlook Q4 FY22 expected to be strongest quarter to date For personal use only FY22 Outlook • Q4 FY22 has started strongly – increased sales to existing retail distribution partners and – a significant pipeline of near term sales opportunities under negotiation • Early indications of s
Slide 16: Contact details
For personal use only Contact details: Blair Norfolk, CEO e: blair@activated.co Douglas Loh, CFO e: douglas@activated.co Websites: biomeaustralia.com activatedprobiotics.com.au activatednutrients.com activatedxperformance.com.au Biome Australia Limited March Quarter Update (April 2022) Commercial in